EUVIMEDEUVIMED entdecken
Übersichtsarbeit

On‐Demand Generation of Patient‐Derived Organoids for Precision Oncology: Progress and Prospects

Ziliang Guo iD, Shijie Yang iD, Keyu Shen iD, Yumeng Liu iD, Xiequn Xu iD

Advanced Healthcare Materials · 2026-11 · 15 (41)

DOI: 10.1002/adhm.71817 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, online erschienen am 09.10.2026. Verfasst von Ziliang Guo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, …. Hauptthemen laut MEDLINE: Organoids, Precision Medicine, Neoplasms, Medical Oncology. Die Arbeit nennt 149 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Precision oncology has become a focus of both clinical practice and basic research. With the rapid evolution of organoid culture techniques and the integration of biomedical engineering approaches, patient‐derived organoid (PDO) systems are playing an increasingly pivotal role in precision cancer therapy. By recapitulating patient‐specific tumor characteristics, these platforms demonstrate considerable potential for clinical translation. Despite remarkable progress, the impact of PDO models on real‐world therapeutic decision‐making remains limited. Most existing studies have focused on preclinical concept validations or small‐scale trials, leaving a substantial gap before these models can be implemented to guide individualized cancer therapy. This review examines on‐demand PDO generation through the selection of sample‐processing methods, matrices, and platform architectures matched to specific treatment‐response questions. We compare conventional and engineered systems in terms of biological complexity, sample requirements, reported timelines, assay readouts, and clinical evidence. Particular attention is given to engineering trade‐offs and the distinction between technical feasibility, clinical response correlation, and demonstrated utility in treatment selection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OrganoidsPrecision MedicineNeoplasmsMedical OncologyHumansAnimals

Stichwörter der Autor:innen

clinical practiceon‐demand tumor modelingpatient‐derived organoidspersonalized cancer therapy

Autor:innen und Institutionen

  • Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Department of Radiation Oncology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

ORCID-Profile: Ziliang Guo, Shijie Yang, Keyu Shen, Yumeng Liu, Xiequn Xu

Zitieren

APA

Guo, Z., Yang, S., Shen, K., Liu, Y., & Xu, X. (2026). On‐Demand Generation of Patient‐Derived Organoids for Precision Oncology: Progress and Prospects. Advanced Healthcare Materials, 15(41). https://doi.org/10.1002/adhm.71817

Vancouver

Guo Z, Yang S, Shen K, Liu Y, Xu X. On‐Demand Generation of Patient‐Derived Organoids for Precision Oncology: Progress and Prospects. Advanced Healthcare Materials. 2026;15(41). doi:10.1002/adhm.71817

BibTeX
@article{Guo2026,
  author = {Guo, Ziliang and Yang, Shijie and Shen, Keyu and Liu, Yumeng and Xu, Xiequn},
  title = {On‐Demand Generation of Patient‐Derived Organoids for Precision Oncology: Progress and Prospects},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  volume = {15},
  number = {41},
  doi = {10.1002/adhm.71817}
}
Kostenlos starten →